Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Stockholm, Sweden, 29 August: Multivessel and left main disease have been long considered as mainstay indications for coronary artery bypass grafting surgery (CABG). This recommendation, however, has been strongly challenged on several occasions. The release of new Myocardial Revascularisation guidelines by ESC and the European Association of Cardio-Thoracic Surgeons (EACTS) at the ESC Congress on Sunday 29 August is likely to shed new light on what has become a controversial topic.
As recently as 2009, the American College of Cardiology issued its Appropriateness Criteria for Coronary Revascularization document (ACCR) in which both multivessel and left main disease subsets are considered surgical indications – and therefore appropriate for CABG – rather than indications for percutaneous coronary intervention (PCI) using stents. The ACCR document suggests that PCI is inappropriate for left main disease and uncertain for multivessel disease.
Doctor William Wijns of the OLV Hospital in Aalst, Belgium was Co-Chair of the ESC/EACTS Task Force that prepared the new guidelines. He believes that the deep insight gained while reviewing the available evidence and developing the guidelines will give better information and guidance on the issue of when to use CABG and PCI for multivessel and left main disease. “There is some evidence to suggest that we should revisit established practice and review the recommendations contained in the ACCR,” he said. “The new guidelines we have written represent, for the first time, consensus opinion between clinical-non interventional cardiologists, interventional cardiologists and cardiac surgeons.”
The new Myocardial Revascularisation Guidelines are the result of co-operation between the ESC and EACTS. They were written by a Task Force of 25 experts made up of surgeons and cardiologists drawn from both organisations. The Task Force was jointly led by Doctor Wijns and Professor Philippe Kolh of EACTS, and copies of the guidelines can be downloaded at http://authors.escardio.org/guidelines-surveys/esc-guidelines.
This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2010. The press release has been written and/or edited by the ESC from information provided by the investigator and does not necessarily reflect the opinion of the European Society of Cardiology. The content of the press release has been approved by the investigator.
About the European Society of Cardiology The European Society of Cardiology (ESC) represents more than 62,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
About ESC Congress 2010 ESC Congress 2010 will take place from 28 August to 1 September at the Stockholmsmässan, Stockholm. Information on the scientific programme is available at http://spo.escardio.org/Search.aspx?eevtid=40. More information on ESC Congress 2010 is available from the ESC's press office at email@example.com.
Our mission: To reduce the burden of cardiovascular disease
© 2019 European Society of Cardiology. All rights reserved